NCT06115083

Brief Summary

The goal of this randomized controlled study is to establish the long-term effect of pelvic floor re-education using biofeedback and home training for men with chronic pelvic pain. The main questions it aims to answer are if pelvic floor re-education using bio-feedback and home training will give a long-lasting improvement in symptoms, assessed with a validated symptom score (the National Institute of Health - Chronic Prostatitis Symptom Index) and if an improvement in symptoms can be correlated to objective measurements of pelvic floor function. Participants will be asked to do pelvic floor exercises daily during six months with additional sessions of bio-feedback training. The control group will have no changes in their on-going treatment for their chronic pelvic pain and will be offered to enter the treatment group after six months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Dec 2023Dec 2026

First Submitted

Initial submission to the registry

October 17, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
29 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 16, 2024

Status Verified

April 1, 2024

Enrollment Period

3 years

First QC Date

October 17, 2023

Last Update Submit

April 12, 2024

Conditions

Keywords

Chronic pelvic pain syndromeChronic prostatitis with chronic pelvic pain syndromeChronic prostatitisPelvic floor musclesUrodynamicsPhysiotherapyBio-feedback

Outcome Measures

Primary Outcomes (1)

  • Change in symptom score on the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire

    Change in total score, range from 0-43 points. Higher score indicates worse symptoms.

    Measured 3, 6 and 12 months after inclusion

Secondary Outcomes (7)

  • Change in sub score on the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire

    Measured 3, 6 and 12 months after inclusion

  • Changes in global voiding function using free flow non-invasive urodynamic testing

    Measured 6 and 12 months after inclusion

  • Changes in global storing function of the bladder using invasive urodynamics, cystometry

    Measured 6 and 12 months after inclusion

  • Changes in global voiding function using invasive urodynamics, pressure-flow study

    Measured 6 and 12 months after inclusion

  • Changes in urethral pressure using invasive urodynamics, urethral pressure profile

    Measured 6 and 12 months after inclusion

  • +2 more secondary outcomes

Study Arms (2)

Pelvic floor muscle re-education

EXPERIMENTAL

Intervention with pelvic floor re-education using bio-feedback and home training for 6 months, with a follow up visit after an additional period of 6 months

Other: Pelvic floor re-education using bio-feedback and home training

Standard Care

NO INTERVENTION

No intervention during 6 months after inclusion. After the 6 month follow-up evaluation the study subjects are offered to participate in the interventional arm.

Interventions

Pelvic floor re-education using bio-feedback and home training

Pelvic floor muscle re-education

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men over the age of 18, residents in Sweden, diagnosed with Chronic Primary Pelvic Pain Syndrome (CPPPS) according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (N41.1 (chronic prostatitis), N41.9 (Inflammatory disease of prostate, unspecified), N50.8F (Chronic Pelvic Pain Syndrome in men)

You may not qualify if:

  • Cancer in the abdomen or pelvic organs (current or previous)
  • Congenital anomalies affecting the pelvic region (Bladder exstrophy, Myelomeningocele etc.)
  • Transsexual male, (i.e. at birth biologically female)
  • Diseases affecting the nerve function to the pelvic and/or lower extremities, other disease or ongoing treatment that could have an impact on the outcome of the study.
  • Incapability to participate in testing or follow training instructions due to mental incapacity, language difficulties etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, 141 86, Sweden

RECRUITING

Related Publications (1)

  • Hallencreutz Grape H, Nordgren B, Renstrom Koskela L. Long-term effects of pelvic floor training in male chronic pelvic pain, correlation between subjective and objective outcomes: a study protocol for a randomised controlled trial. BMJ Open. 2024 Nov 4;14(11):e087620. doi: 10.1136/bmjopen-2024-087620.

MeSH Terms

Conditions

Prostatitis

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Lotta Renström Koskela, M.D

    Karolinska University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The interpreter of the urodynamic evaluations will be blinded regarding intervention/control group
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized controlled single blinded clinical study with a study period of 12 months from inclusion until completion. The study subjects are then randomly assigned in a 1:1 ratio either to treatment or control group. After 6 months the study subjects in the control group are offered to be included in the intervention group.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 17, 2023

First Posted

November 2, 2023

Study Start

December 1, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 16, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations